Identification of AQW051, an alpha7 nicotinic acetylcholine receptor partial agonist for the treatment of cognitive impairment associated with schizophrenia

被引:0
|
作者
Hurth, Konstanze [1 ]
Gomez-Mancilla, Baltazar [1 ]
Hoyer, Daniel [4 ]
Johns, Donald [2 ]
Lopez, Cristina Lopez [3 ]
Nozulak, Joachim [1 ]
Ritchie, Timothy J. [5 ]
Troxler, Thomas [1 ]
Weiss, Markus [1 ]
Feuerbach, Dominik [1 ]
机构
[1] Novartis Inst BioMed Res, Basel, Switzerland
[2] Novartis Inst BioMed Res, Cambridge, MA USA
[3] Novartis Pharma AG, Basel, Switzerland
[4] Univ Melbourne, Melbourne, Vic, Australia
[5] TJR Chem, Ranco, Italy
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
222-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [1] AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation
    Feuerbach, Dominik
    Pezous, Nicole
    Weiss, Markus
    Shakeri-Nejad, Kasra
    Lingenhoehl, Kurt
    Hoyer, Daniel
    Hurth, Konstanze
    Bilbe, Graeme
    Pryce, Christopher R.
    McAllister, Kevin
    Chaperon, Frederique
    Kucher, Klaus
    Johns, Donald
    Blaettler, Thomas
    Lopez Lopez, Cristina
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (05) : 1292 - 1304
  • [2] Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625
    Marquis, Karen L.
    Comery, Thomas A.
    Jow, Flora
    Navarra, Rachel L.
    Grauer, Steven M.
    Pulicicchio, Claudine
    Kelley, Cody
    Brennan, Julie A.
    Roncarati, Renza
    Scali, Carla
    Haydar, Simon
    Ghiron, Chiara
    Terstappen, Georg C.
    Dunlop, John
    [J]. PSYCHOPHARMACOLOGY, 2011, 218 (04) : 635 - 647
  • [3] Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625
    Karen L. Marquis
    Thomas A. Comery
    Flora Jow
    Rachel L. Navarra
    Steven M. Grauer
    Claudine Pulicicchio
    Cody Kelley
    Julie A. Brennan
    Renza Roncarati
    Carla Scali
    Simon Haydar
    Chiara Ghiron
    Georg C. Terstappen
    John Dunlop
    [J]. Psychopharmacology, 2011, 218 : 635 - 647
  • [4] AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces L-Dopa-induced dyskinesias and extends the duration of L-Dopa effects in parkinsonian monkeys
    Di Paolo, Therese
    Gregoire, Laurent
    Feuerbach, Dominik
    Elbast, Walid
    Weiss, Markus
    Gomez-Mancilla, Baltazar
    [J]. PARKINSONISM & RELATED DISORDERS, 2014, 20 (11) : 1119 - 1123
  • [5] Effects of alpha7 nicotinic receptor agonist TC-5619 in cognitive dysfunction in schizophrenia
    Dunbar, G.
    Hosford, D.
    Segreti, A.
    Lieberman, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S522 - S522
  • [6] Alpha7 nicotinic acetylcholine receptor agonist improves survival during endotoxemia
    Chen, F.
    Cai, B.
    Dong, W.
    Deitch, E. A.
    Ulloa, L.
    [J]. SHOCK, 2008, 29 : 80 - 80
  • [7] The Alpha7 nicotinic acetylcholine receptor is target for the treatment of skin fibrosis
    Boehm, M.
    Stegemann, A.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2019, 81 : 49 - 50
  • [8] Increased brain cytokine level associated impairment of vigilance and memory in aged rats can be alleviated by alpha7 nicotinic acetylcholine receptor agonist treatment
    Bali, Zsolt Kristof
    Nagy, Lili Veronika
    Bruszt, Nora
    Bodo, Kornelia
    Engelmann, Peter
    Hernadi, Zsofia
    Gonter, Kitti
    Tadepalli, Sai Ambika
    Hernadi, Istvan
    [J]. GEROSCIENCE, 2024, 46 (01) : 665 - 682
  • [9] Increased brain cytokine level associated impairment of vigilance and memory in aged rats can be alleviated by alpha7 nicotinic acetylcholine receptor agonist treatment
    Zsolt Kristóf Bali
    Lili Veronika Nagy
    Nóra Bruszt
    Kornélia Bodó
    Péter Engelmann
    Zsófia Hernádi
    Kitti Göntér
    Sai Ambika Tadepalli
    István Hernádi
    [J]. GeroScience, 2024, 46 : 645 - 664
  • [10] Silent agonists for alpha7 nicotinic acetylcholine receptor
    Chojnacka, Kinga
    Papke, Roger L.
    Horenstein, Nicole A.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246